TABLE 6.
Fold changes in fasted serum metabolite concentrations in astronauts with and without pathologic optical changes after flight
| Outcome and metabolic pathway | Metabolite | Change |
|---|---|---|
| Disc edema, total n = 48 | ||
| Histidine metabolism | 1-Methylhistidine | 1.30 |
| Imidazole propionate | 1.64 | |
| 1-Methylimidazoleacetate | 1.45 | |
| Methionine metabolism | 2-Aminobutyrate | 1.29 |
| Hypotaurine | 1.80 | |
| N-acetyltaurine | 1.28 | |
| Lipid metabolism | 2-Hydroxyadipate | 1.63 |
| 1-Palmitoylglycerophosphocholine (16:0) | 1.26 | |
| 2-Palmitoylglycerophosphocholine | 1.16 | |
| 1-Stearoylglycerophosphocholine (18:0) | 1.28 | |
| 2-Stearoylglycerophosphocholine | 1.22 | |
| 1-Oleoylglycerophosphocholine (18:1) | 1.39 | |
| 1-Arachidonoylglycerophosphocholine (20:4n6) | 1.27 | |
| 1-Stearoylglycerophosphoethanolamine | 1.30 | |
| 1-Arachidonoylglycerophosphate | 1.28 | |
| Palmitoyl-arachidonoyl-glycerophosphocholine (2) | 1.26 | |
| Pimelate | 1.52 | |
| Change in diopters, total n = 31 | ||
| Carbohydrate metabolism | Mannose | 1.21 |
| Galactonate | 2.41 | |
| Glucuronate | 1.25 | |
| N-acetylneuraminate | 1.41 | |
| Inositol metabolism | Myo-inositol | 1.27 |
| Chiro-inositol | 2.42 | |
| Scyllo-inositol | 1.40 | |
| Myo-inositol:chiro-inositol | 0.52 | |
| Cotton wool spots, total n = 39 | ||
| Steroid metabolism | Epiandrosterone sulfate | 1.15 |
| 5α-Androstan-3β,17β-diol monosulfate (2) | 1.12 | |
| 5α-Androstan-3β,17β-diol disulfate | 1.47 | |
| 5α-Androstan-3α,17β-diol monosulfate (2) | 2.30 | |
| Xanthine metabolism | 3,7-Dimethylurate | 1.49 |
| 3-Methylxanthine | 1.62 | |
| 7-Methylxanthine | 1.39 |
All of the fold changes in this table were significant at q < 0.2, or the metabolite was in a metabolic pathway in which at least 2 other metabolites were significant. P < 0.05.